Prospective Prostate Cancer Infrastructure
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to collect detailed long-term real-world data and biomaterials from men with high-risk localized prostate cancer and synchronous metastatic hormone-sensitive prostate cancer. This will help to better understand how these patients are treated in daily practice, how treatments affect quality of life, and facilitate biomarker discovery. The infrastructure is also designed to enable future cohort multiple randomized controlled trials.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Rozpoznanie raka prostaty wysokiego ryzyka lub raka prostaty z przerzutami potwierdzone badaniami obrazowymi lub biopsją
- •Rak gruczołowy prostaty (ewentualnie z komponentami neuroendokrynnym)
- •Wiek co najmniej 18 lat
- •Pisemna zgoda na udział w badaniu
- •Znajomość co najmniej jednego z języków: holenderski, angielski, arabski lub turecki
✗ Disqualifies
- •Aktualnie nie mieszka w Holandii
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 10, 2026
- Sex
- Male only
Locations (1)
Radboud University Medical Center
Nijmegen, Netherlands
Trial contact
Niven Mehra, PhD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.